The Cell Therapy Manufacturing Patent Nobody Budgets For Until the CDMO Contract Falls Through
In January 2022, Lonza Walkersville and its joint-venture partner Octane Biotech sued Miltenyi Biotec in the District of Maryland, alleging
The Double Patenting Defense That Nearly Erased Tamiflu’s Last Patent
On April 22, 2014, the Federal Circuit vacated a patent infringement judgment that Gilead Sciences had already won. The drug
The Double Patenting Defense That Nearly Erased Tamiflu’s Last Patent Read Post »
mRNA Platform Patents Are Colliding. Here Is What That Means For The Next Filer
Nine separate patent holders have asserted rights against a single COVID-19 vaccine, Comirnaty, since August 2022. Two more have asserted
mRNA Platform Patents Are Colliding. Here Is What That Means For The Next Filer Read Post »
Bio-Betters Aren’t a Biosimilar Defense — They’re an Admission the Original Patent Wasn’t Strong Enough
On August 18, 2023, the FDA approved Eylea HD, Regeneron’s 8 mg reformulation of its blockbuster eye drug aflibercept. Nine
The Compulsory License Nobody Expects Until a Government Invokes It
In October 2001, the United States government came within a phone call of doing something it had never done to
The Compulsory License Nobody Expects Until a Government Invokes It Read Post »
Your US Patent Strategy Doesn’t Translate to India. That Gap Is Where the Supply Chains Get Built.
On March 20, 2026, a secondary patent covering Novo Nordisk’s semaglutide formulation expired in India. Within days, Torrent Pharmaceuticals and
Your Global Launch Sequence Assumes Uniform Patent Life. That Assumption Costs Market Share.
Samsung Bioepis launched Benepali, a biosimilar of Amgen’s Enbrel (etanercept), across the European Union on January 16, 2016 [4]. Ten
You Found the Patent. Did You Find the Company That Owns It?
On November 12, 2003, U.S. Patent 5,736,137 changed hands. The patent covers the chimeric antibody that became Rituxan, and the
You Found the Patent. Did You Find the Company That Owns It? Read Post »
The Patent Owner on Your Screen May Not Own the Patent Anymore
The Short Answer Search a drug’s core patent on Google Patents, Espacenet, or the USPTO’s own Patent Public Search, and
The Patent Owner on Your Screen May Not Own the Patent Anymore Read Post »
